• Shire mulls over separation of neuroscience unit pharmatimes
    August 07, 2017
    Shire is considering cleaving its neuroscience division into a separate, publicly-listed entity in a move that would afford the firm a sharper focus on rare diseases
PharmaSources Customer Service